Embolization as one modality in a combined strategy for the management of cerebral arteriovenous malformations

Interventional Neuroradiology

Volumn 11, Issue SUPPL. 1, 2005, Pages 57-62

  Raymond, Jean ^a   Iancu, D ^a   Weill, A ^a   Guilbert, F ^a   Bahary, J P ^a   Bojanowski, M ^a   Roy, D ^a  

^a NOTRE DAME HOSPITAL   (Canada)

Author keywords

AVMs; Embolization; Therapeutic neuroradiology

Indexed keywords

CONTRAST MEDIUM; ENBUCRILATE; ETHYLENE VINYL ALCOHOL COPOLYMER; IODINATED POPPYSEED OIL;

ADULT; ARTIFICIAL EMBOLISM; BRAIN ARTERIOVENOUS MALFORMATION; BRAIN HEMORRHAGE; CLINICAL FEATURE; FEMALE; HUMAN; INTERVENTIONAL RADIOLOGY; MAJOR CLINICAL STUDY; MALE; MICROSURGERY; MORTALITY; NEURORADIOLOGY; NONSURGICAL INVASIVE THERAPY; PROGNOSIS; RADIOSURGERY; RANKIN SCALE; RETROSPECTIVE STUDY; REVIEW; SEIZURE; STEREOTAXIC SURGERY; TREATMENT OUTCOME;

EID: 27844473205     PISSN: 11239344     EISSN: None     Source Type: Journal    
DOI: 10.1177/15910199050110s110     Document Type: Review

References (29)

1. Soderman M, Andersson T et Al: Management of patients with brain arteriovenous malformations. Eur J Radiol 46: 195-205, 2003.
2. Lawton MT: Spetzler-Martin grade III arteriovenous malformations: Surgical results and a modification of the grading scale. Neurosurgery 52: 740-749, 2003.
3. Chang SD, Marcellus ML et Al: Multimodality treatment of giant intracranial arteriovenous malformations. Neurosurgery 53: 1-13, 2003.
4. Han PP, Ponce FA et Al: Intention-to-treat analysis of Spetzler-Martin grades IV and V arteriovenous malformations: Natural history and treatment paradigm. J Neurosurg 98: 3-7, 2003.
5. Debrun G, Vinuela F et Al: Embolization of cerebral arteriovenous malformations with bucrylate. J Neurosurg 56: 615-627, 1982.
6. Drake CG: Cerebral arteriovenous malformations: Considerations for and experience with surgical treatment in 166 cases. Clin Neurosurg 26: 145-208, 1979.
7. Raupp EF, Fernandes J: Does treatment with n-butyl cyanoacrylate embolization protect against hemorrhage in cerebral arteriovenous malformations? Arq Neuropsiquiatr 63: 34-39, 2005.
8. Moret J, Hammami N et Al: Traitement des malformations artério-veineuses cérébrales par l'ONYX. A propos d'une série de 94 patients. XXXII Congrès Annuel de la Société Française de Neuroradiologie 32: 86, 2005.
9. Cekirge S, Saatci I et Al: Is the efficacy of the endovascular treatment in brain AVMs increased by the long intranidal injections of ONYX. Neuroradiology 42: 48-49, 2000.
10. Meisel HJ, Mansmann U et Al: Cerebral arteriovenous malformations and associated aneurysms: Analysis of 305 cases from a series of 662 patients. Neurosurgery 46: 793-800, 2000.
11. Pierot L, Cognard C et Al: Cerebral arteriovenous malformations: Evaluation of the hemorrhagic risk and its morbidity. J Neuroradiol 31: 369-375, 2004.
12. Ogilvy CS, Stieg PE et Al: AHA scientific statement: Recommendations for the management of intracranial arteriovenous malformations: A statement for healthcare professionals from a special writing group of the Stroke council, American Stroke Association. Stroke 32: 1458-1471, 2001.
13. Ondra SL, Troupp H et Al: The natural history of symptomatic arteriovenous malformations of the brain: A 24-year follow-up assessment. J Neurosurg 73: 387-391, 1990.
14. Halim AX, Johnston SC et Al: Longitudinal risk of intracranial hemorrhage in patients with arteriovenous malformation of the brain within a defined population. Stroke 35: 1697-1702, 2004.
15. Stefani MA, Porter PJ et Al: Large and deep brain arteriovenous malformations are associated with risk of future hemorrhage. Stroke 33: 1220-1224, 2002.
16. Bollet MA, Anxionnat R et Al: Efficacy and morbidity of arc-therapy radiosurgery for cerebral arteriovenous malformations: A comparison with the natural history. Int J Radiat Oncol Biol Phys 58: 1353-1363, 2004.
17. Hamilton MG, Spetzler RF: The prospective application of a grading system for arteriovenous malformations. Neurosurgery 34: 2-7, 1994.
18. Morgan MK, Winder M et Al: Delayed hemorrhage following resection of an arteriovenous malformation in the brain. J Neurosurg 99: 967-971, 2003.
19. Morgan MK, Rochford AM et Al: Surgical risks associated with the management of grade I and II brain arteriovenous malformations. Neurosurgery 54: 832-839, 2004.
20. Zhao J, Wang S et Al: Clinical characteristics and surgical results of patients with cerebral arteriovenous malformations. Surg Neurol 63: 156-161, 2005.
21. Hartmann A, Pile-Spellman J et Al: Risk of endovascular treatment of brain arteriovenous malformations. Stroke 33: 1816-1820, 2002
22. Taylor CL, Dutton K et Al: Complications of preoperative embolization of cerebral arteriovenous malformations. J Neurosurg 100: 810-812, 2004.
23. Meisel HJ, Mansmann U et Al: Effect of partial targeted n-butyl-cyano-acrylate embolization in brain AVM. Acta Neurochir 144: 879-888, 2002.
24. Andaluz N, Myseros JS et Al: Recurrence of cerebral arteriovenous malformations in children: Report of two cases and review of the literature. Surg Neurol 62: 324-330, 2004.
25. Picard L, Da Costa E et Al: Acute spontaneous hemorrhage after embolization of brain arteriovenous malformation with n-butyl cyanoacrylate. J Neuroradiol 28: 147-165, 2001.
26. Izawa M, Hayashi M et Al: Long-term complications after gamma knife surgery for arteriovenous malformations. J Neurosurg 102: 34-37, 2005.
27. Maruyama K, Kawahara N et Al: The risk of hemorrhage after radiosurgery for cerebral arteriovenous malformations. N Engl J Med 352: 146-153, 2005.
28. Al-Shahi R, Bhattacharya JJ et Al: Prospective, population-based detection of intracranial vascular malformations in adults: The Scottish Intracranial Vascular Malformation Study (SIVMS). Stroke 34: 1163-1169, 2003.
29. Stapf C, Mast H et Al: The New York islands AVM study: Design, study progress, and initial results. Stroke 34: 29-33, 2003.